Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gynecologic 2Thoracic 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Leukemia, Myeloid, Acute 137Precursor Cell Lymphoblastic Leukemia-Lymphoma 136Leukemia 133Lymphoma 129Lymphoma, Non-Hodgkin 123Multiple Myeloma 116Leukemia, Lymphocytic, Chronic, B-Cell 115Lymphoma, Follicular 114Lymphoma, Large B-Cell, Diffuse 113Hodgkin Disease 106Lymphoma, Mantle-Cell 102Myelodysplastic Syndromes 98Lymphoma, Large-Cell, Immunoblastic 95Burkitt Lymphoma 93Lymphoma, B-Cell, Marginal Zone 80Leukemia, Myeloid, Chronic-Phase 75Congenital Abnormalities 75Leukemia, Myeloid, Accelerated Phase 73Myeloproliferative Disorders 70Neoplasms, Plasma Cell 63Leukemia, Myelomonocytic, Chronic 62Blast Crisis 57Waldenstrom Macroglobulinemia 52Recurrence 46Breast Neoplasms 45Primary Myelofibrosis 44Lymphoma, T-Cell, Cutaneous 42Anemia, Refractory, with Excess of Blasts 39Sezary Syndrome 38Mycosis Fungoides 38

Interventions

Ifosfamide 5Filgrastim 5Doxorubicin 5Gemcitabine 4Docetaxel 4Radiotherapy 3Proton Therapy 3Carboplatin 3regorafenib 2ivosidenib 2enasidenib 2belinostat 2Sunitinib 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Immune Checkpoint Inhibitors 2HhAntag691 2Fluorouracil 2Etoposide 2Epirubicin 2Cyclophosphamide 2Cisplatin 2Chemotherapy, Adjuvant 2Celecoxib 2Bevacizumab 2venetoclax 1toripalimab 1temsirolimus 1tanespimycin 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Chondrosarcoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡